Categories Consumer, Earnings

International Speedway Q1 results fail to meet estimates

International Speedway Corp. (ISCA) reported first quarter 2019 financial results, which failed to meet the expectations of the Street. The racetrack operator’s earnings stood at $0.57 per share on revenue of $150.6 million for the quarter ended February 28, 2019.

Market watchers expected the company’s earnings to remain unchanged at $0.60 per share as in the prior year and revenues to move up 1.4% year-over-year to $151 million. ISCA stock is down about 1% in the pre-market trading.

The Daytona Beach, Florida-based company reaffirmed its guidance for fiscal year 2019. International Speedway expects non-GAAP EPS to be in the range of $1.85 to $2.15 and revenue to be in the range of $685 million to $705 million.

Check out International Speedway’s (ISCA) previous quarters’ earnings transcripts here

“Financial results for the first quarter are in line with our 2019 outlook,” stated Lesa France Kennedy, CEO.

In Q1, ISC recognized approximately $2.8 million, or $0.05 per share, of costs incurred associated with the pending non-binding proposal by NASCAR Holdings to acquire the outstanding shares of Class A and Class B common stock that are not owned by the controlling shareholders of NASCAR.

Last month, rival racetrack operator Speedway Motorsports (TRK) reported a 27% plunge in fourth-quarter revenues to $56.36 million, hurt by muted performance by all the business segments. The company slipped to a loss of $0.30 per share, compared to earnings of $2.77 per share in the year-ago period.

Shares of ISCA have dropped about 1% since the beginning of 2019 and gained 4% in the past 12 months.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips

Most Popular

Cost reduction has become a priority for FedEx (FDX) after a challenging quarter

Shares of FedEx Corporation (NYSE: FDX) were up 1% on Tuesday. The stock has dropped 44% year-to-date and 34% over the past 12 months. The company delivered mixed results for

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered the stock market. On the heels of AIG

Stock Watch: Is Darden Restaurants a good buy after earnings?

After a prolonged slowdown, the restaurant industry is returning to normal patterns but macroeconomic uncertainties and high inflation are currently playing spoilsport for it. While the pandemic-related slump forced many

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top